Related Experiment Video
Updated: Jun 28, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Notch signaling in pediatric malignancies
1The Children's Cancer Hospital, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 853, Houston, TX 77030, USA. PZweidler@MDAnderson.org
Abstract:
Notch signaling plays crucial roles in many developmental pathways, with Notch mutations linked to several developmental disorders. Because many pediatric malignancies arise from dysregulated development, roles for Notch signaling in these cancers are to be expected. Evidence to support this is now emerging as the Notch pathway is being explored in more pediatric cancers. Not surprisingly, Notch appears to play diverse roles in different malignancies, effecting differentiation, metastasis, cancer "stem cells," and angiogenesis. As examples, although activating mutations of Notch1 are found in the majority of T-cell acute lymphoblastic leukemia (ALL) cases, Notch/HES1 signaling appears to play a tumor suppressor role in precursor B-cell ALL; although Notch/HES1 signaling appears to contribute to osteosarcoma metastasis, Notch signaling also promotes medulloblastoma "stem cell" survival and contributes to angiogenesis in neuroblastoma. Further understanding of the roles of Notch signaling in specific pediatric cancers will provide a rationale for Notch-based therapeutic strategies.
Insights
Notch signaling impacts pediatric cancers, influencing tumor growth, spread, and stem cells. Understanding its varied roles is key to developing targeted therapies for these diseases.
Area of Science:
- Oncology
- Developmental Biology
- Molecular Signaling
Background:
- Notch signaling is vital for development and linked to developmental disorders.
- Pediatric malignancies often stem from disrupted developmental processes.
- The Notch pathway's role in pediatric cancers is increasingly recognized.
Purpose of the Study:
- To explore the multifaceted roles of Notch signaling in various pediatric cancers.
- To identify how Notch pathway dysregulation contributes to cancer development and progression.
- To lay the groundwork for Notch-targeted therapeutic strategies in pediatric oncology.
Main Methods:
- Review of existing literature on Notch signaling in pediatric malignancies.
- Analysis of specific pediatric cancer types where Notch pathway alterations are implicated.
- Correlation of Notch pathway activity with cancer hallmarks like differentiation, metastasis, and angiogenesis.
Main Results:
- Notch signaling exhibits diverse functions across different pediatric cancers.
- Activating Notch1 mutations are prevalent in T-cell acute lymphoblastic leukemia (ALL).
- Notch/HES1 signaling acts as a tumor suppressor in precursor B-cell ALL but promotes osteosarcoma metastasis.
Conclusions:
- Notch signaling plays complex, context-dependent roles in pediatric cancers.
- Its involvement spans differentiation, metastasis, cancer stem cells, and angiogenesis.
- Further research into Notch signaling in specific pediatric cancers is crucial for therapeutic development.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
